About Enclara Pharmacia

Mark Morse joined Enclara Pharmacia as CEO after nearly 20 years at Enclara’s parent company, Humana, where he led efforts around sales, systems development and customer-focus. He most recently served as vice president of pharmacy service operations, overseeing operations and strategy for Humana Pharmacy’s consumer interactions and contact centers with a team of approximately 3,000 associates in 16 different domestic and overseas locations. Under his leadership, Humana was consistently named the best in Mail Order Pharmacy Customer Satisfaction in the J.D. Power U.S. 2020 Pharmacy Study.

Mark’s previous roles at Humana included serving as practice leader for PBM sales and client services and directing corporate sales for national and major accounts. Prior to joining Humana in 2020, he spent six years with United Healthcare, serving as the business owner for its consumer portal and operations director for health plan and systems migrations.

Mark holds a Bachelor of Science in Management Systems from Rensselear Polytechnic Institute, America’s first technological research university.

As Chief Commercial Officer, Scott Quilty drives Enclara’s strategic direction around business development, client services and marketing. Prior to joining Enclara in 2020, Scott spent over two decades in a variety of leadership roles at B. Braun Medical where he led cross-functional corporate transformation initiatives and built high-performing organizations. He concluded his tenure at B Braun as Corporate Vice President. Scott grew up in Dayton, Ohio and holds a Bachelor of Business Administration from the University of Cincinnati.

As Chief Administrative Officer and General Counsel, Scott manages Enclara Pharmacia’s Compliance, Human Resources, Insurance and Legal functions. Scott has devoted his entire career to healthcare, previously having served in various leadership roles within the administrative, finance and legal functions of some of the nation’s leading healthcare providers and service organizations. Scott previously served as Budget Manager for New York Presbyterian Hospital, a comprehensive university hospital, as well as Operations Director for the faculty practice facility of Rutgers University / New Jersey Medical School. Immediately prior to joining Enclara Pharmacia, Scott was a partner with Norris, McLaughlin & Marcus, a 150+ attorney regional law firm, where his practice was devoted to assisting diverse healthcare providers/suppliers and other corporate clients solve complex transactional, regulatory and compliance issues. Scott earned his undergraduate degree from the University of Arizona, his MBA from Fairleigh Dickinson University and his law degree from Seton Hall University. 

Deanna has been working in the hospice industry for over 15 years. She received her BS Pharmacy and Doctor of Pharmacy from St. Louis College of Pharmacy. As a licensed pharmacist, she has worked in a variety of pharmacy settings including retail, hospital and long term care. She has consulted with hospices across the country to reduce medication cost and improve patient care through appropriate medication selection and best practice guidelines. Deanna has spoken nationally on a variety of topics including pain management, methadone and adjuvant therapies.  Prior to becoming Senior VP, Sales for Enclara Pharmacia, Deanna managed client services and business development for Hospice Pharmacia.

Rushi is a nationally prominent pharmacist who brings more than 15 years of managerial and operational experience to Enclara. He has worked in a variety of settings, including hospital pharmacy, retail pharmacy and long-term care pharmacy.

Rushi began his pharmacy career as a clinical coordinator and supervisor at 500+ bed acute care hospital, and later ventured into retail and long-term care pharmacy, where he assumed leadership roles in pharmacy operations, regulatory, compliance and government affairs. He has significant operational, regulatory and licensing experience, including experience with sterile and non-sterile compounding.

Rushi holds a doctor of pharmacy degree and is a graduate of University of the Sciences in Philadelphia, Philadelphia College of Pharmacy.

As VP, Information Technology, Kerry Lord oversees Enclara’s enterprise systems, software development, interfaces, business applications, and business intelligence. He previously spent 15 years managing software development at the company. During that time, he led a variety of innovative projects, including Enclara’s first E3 Mobile app and the Electronic Prescriptions for Controlled Substances (EPCS) certification process. Prior to joining Enclara, he managed IT operations for an early adopter of online retailing technology. Kerry holds a B.S. in Aviation/Airway Management and Operations from Jacksonville University and is an expert on Moicrosoft.NET (C#) and SQL Server as well as many other supporting technologies.

Andy Horowitz is a leader and entrepreneur in the post-acute healthcare industry. An attorney by education, he has founded several regional and national companies. In 2006, he founded hospice specialty pharmacy provider Enclara Health. In 2013, Andy founded Turn-Key Health as a subsidiary of Enclara Health focused on solving the problem of poor quality, low satisfaction and extreme high cost during the last years of life.

In 2014 Andy created Enclara Healthcare and partnered with Consonance Capital Partners to purchase and combine excelleRx/Hospice Pharmacia with Enclara Health to create Enclara Pharmacia, which now serves over a third of the hospice through comprehensive mail order and local pharmacy offerings, digital solutions and clinical support. The deal also included PBM Plus, which was integrated into Enclara Healthcare to create GuidantRx, a boutique pharmacy benefit management provider specializing in self-insured employer pharmacy benefits management and co-pay card services. Enclara Healthcare would grow to be leading solutions provider focused on simplifying care delivery in complex care populations to improve patient experience, quality and cost.

In 2020, Andy, together with Consonance Capital Partners, sold Enclara Healthcare, including Enclara Pharmacia and GuidantRx, to Humana. Turn-Key Health was sold in a separate transaction to CareCentrix. Andy led Enclara Healthcare through a successful transition period before stepping down as CEO in September 2020. He remains affiliated with Enclara as a special advisor to the executive team.

Prior to founding Enclara, Andy founded Partners Healthcare, which focused on the institutional long-term care pharmacy market, and Solutions Homecare, a JCAHO-accredited infusion therapy company. He also acquired a New Jersey based hospice business known as Garden State Hospice and, after rebranding as Care Alternatives, developed it into a large, regional hospice services company providing care to approximately 800 patients per day. Between 1998 and 2004, Andy grew these companies into one of the largest privately held institutional pharmacies and hospices in the country, serving six states, until he sold the combined business in 2004.